VisionQuest Biomedical

About:

VisionQuest Biomedical is a medical device company using artificial intelligence to end preventable blindness.

Website: http://www.visionquest-bio.com

Twitter/X: vqbiomed

Top Investors: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Description:

VisionQuest Biomedical is a medical device company using artificial intelligence to end preventable blindness. EyeStar, the company's first software application, is used to diagnose diabetic retinopathy in patients' eyes, and Aspire detects malarial retinopathy. The new i-RxTherm is VisionQuest's first technological effort to detect early-stage diabetic disease in areas other than the eyes. VisionQuest's mission is to create and deploy image-based technologies that will improve access to health care for millions of people in the United States and around the world, particularly in the areas of diabetes and eye care.

Total Funding Amount:

$24.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Albuquerque, New Mexico, United States

Founded Date:

2007-07-01

Contact Email:

sbarriga(AT)visionquest-bio.com

Founders:

Peter Soliz, Simon Barriga

Number of Employees:

11-50

Last Funding Date:

2022-10-10

IPO Status:

Private

© 2024 MyAiNote.com